These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 6405420)
21. Comparison of the activity of 2'-deoxycoformycin and erythro-9-(2-hydroxy-3-nonyl)adenine in vivo. Plunkett W; Alexander L; Chubb S; Loo TL Biochem Pharmacol; 1979; 28(2):201-6. PubMed ID: 426835 [No Abstract] [Full Text] [Related]
22. Endogenous adenosine modulation of 22Na uptake by rat brain synaptosomes. Ribeiro JA; Lobo MG; SebastiĆ£o AM Neurochem Res; 2003 Oct; 28(10):1591-5. PubMed ID: 14570405 [TBL] [Abstract][Full Text] [Related]
23. Niacin prevents DNA strand breakage by adenosine deaminase inhibitors. Weitberg AB; Corvese D Biochem Biophys Res Commun; 1990 Mar; 167(2):514-9. PubMed ID: 2322239 [TBL] [Abstract][Full Text] [Related]
24. Protective effects of an adenosine deaminase inhibitor on ischemia-reperfusion injury in isolated perfused rat heart. Zhu QY; Chen SG; Zou CM Am J Physiol; 1990 Sep; 259(3 Pt 2):H835-8. PubMed ID: 2396691 [TBL] [Abstract][Full Text] [Related]
25. Adenosine deaminase inhibitors. Synthesis and biological evaluation of C1' and nor-C1' derivatives of (+)-erythro-9-(2(S)-hydroxy-3(R)-nonyl)adenine. Harriman GC; Poirot AF; Abushanab E; Midgett RM; Stoeckler JD J Med Chem; 1992 Oct; 35(22):4180-4. PubMed ID: 1433220 [TBL] [Abstract][Full Text] [Related]
26. Effect of adenosine deaminase inhibitors on the heart's functional and biochemical recovery from ischemia: a study utilizing the isolated rat heart adapted to 31P nuclear magnetic resonance. Dhasmana JP; Digerness SB; Geckle JM; Ng TC; Glickson JD; Blackstone EH J Cardiovasc Pharmacol; 1983; 5(6):1040-7. PubMed ID: 6196552 [TBL] [Abstract][Full Text] [Related]
27. Low-toxicity immunosuppression by specific inhibition of adenosine deaminase (ADA): prolongation of mouse skin grafts with erythro-9-(2-hydroxy-3-nonyl) adenine hydrochloride (EHNA). Lum CT; Sutherland DE; Foker JE; Najarian JS Surg Forum; 1977; 28():320-2. PubMed ID: 364724 [No Abstract] [Full Text] [Related]
31. Synergistic effect of 3'-deoxyadenosine N1-oxide and adenosine deaminase inhibitors on growth of Ehrlich ascites tumor cells in vivo. Svendsen KR; Overgaard-Hansen K; Frederiksen S Cancer Chemother Pharmacol; 1988; 21(1):35-9. PubMed ID: 3257721 [TBL] [Abstract][Full Text] [Related]
32. Effects of adenosine deaminase inhibition on blood pressure in old spontaneously hypertensive rats. Tofovic SP; Kusaka H; Li P; Jackson EK Clin Exp Hypertens; 1998 Apr; 20(3):329-44. PubMed ID: 9605386 [TBL] [Abstract][Full Text] [Related]
33. Erythro-9-(2-hydroxy-3-nonyl) Adenine alone and in combination with 9-beta-D-arabinofuranosyladenine in treatment of systemic herpesvirus infections in mice. Shannon WM; Arnett G; Schabel FM; North TW; Cohen SS Antimicrob Agents Chemother; 1980 Oct; 18(4):598-603. PubMed ID: 6255863 [TBL] [Abstract][Full Text] [Related]
34. Rat brain adenosine deaminase after 2'-deoxycoformycin administration: biochemical properties and evidence for reduced enzyme levels detected by 2'-[3H]deoxycoformycin ligand binding. Padua RA; Geiger JD; Delaney SM; Nagy JI J Neurochem; 1992 Feb; 58(2):421-9. PubMed ID: 1729390 [TBL] [Abstract][Full Text] [Related]
35. Effects of adenosine deaminase inhibitors on lymphocyte-mediated cytolysis. Wolberg G; Zimmerman TP Ann N Y Acad Sci; 1985; 451():215-26. PubMed ID: 3878118 [TBL] [Abstract][Full Text] [Related]
36. Erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA) blocks differentiation and maintains the expression of pluripotency markers in human embryonic stem cells. Burton P; Adams DR; Abraham A; Allcock RW; Jiang Z; McCahill A; Gilmour J; McAbney J; Kaupisch A; Kane NM; Baillie GS; Baker AH; Milligan G; Houslay MD; Mountford JC Biochem J; 2010 Dec; 432(3):575-84. PubMed ID: 20923411 [TBL] [Abstract][Full Text] [Related]
37. The effects of an induced adenosine deaminase deficiency on T-cell differentiation in the rat. Barton RW Cell Immunol; 1985 Oct; 95(2):297-310. PubMed ID: 3876160 [TBL] [Abstract][Full Text] [Related]
38. Adenosine deaminase inhibitors: synthesis and biological evaluation of unsaturated, aromatic, and oxo derivatives of (+)-erythro-9-(2'S-hydroxy-3'R-nonyl)adenine [(+)-EHNA]. Pragnacharyulu PV; Varkhedkar V; Curtis MA; Chang IF; Abushanab E J Med Chem; 2000 Nov; 43(24):4694-700. PubMed ID: 11101360 [TBL] [Abstract][Full Text] [Related]
39. Inhibitors of adenosine deaminase. Studies in combining high-affinity enzyme-binding structural units. erythro-1,6-Dihydro-6-(hydroxymethyl)-9-(2-hydroxy-3-nonyl)purine and erythro-9-(2-hydroxy-3-nonyl)purine. Woo PW; Baker DC J Med Chem; 1982 May; 25(5):603-5. PubMed ID: 7086847 [TBL] [Abstract][Full Text] [Related]
40. Effect of erythro-9-(2-hydroxy-3-nonyl) adenine on purine and pyrimidine metabolism in the human peripheral lymphocyte during the early phases of phytohemagglutinin-mediated blastogenesis. Skupp S; Vugrek G; Ayvazian JH Biochem Pharmacol; 1979 Nov; 28(22):3323-31. PubMed ID: 526339 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]